Hyperparasitaemic human Plasmodium knowlesi infection with atypical morphology in peninsular Malaysia
© Lee et al.; licensee BioMed Central Ltd. 2013
Received: 29 October 2012
Accepted: 29 January 2013
Published: 6 March 2013
Plasmodium knowlesi is a potentially life-threatening zoonotic malaria parasite due to its relatively short erythrocytic cycle. Microscopic identification of P. knowlesi is difficult, with “compacted parasite cytoplasm” being one of the important identifying keys. This report is about a case of hyperparasitaemic human P. knowlesi infection (27% parasitaemia) with atypical amoeboid morphology. A peninsular Malaysian was admitted to the hospital with malaria. He suffered anaemia and acute kidney function impairment. Microscopic examination, assisted by nested PCR and sequencing confirmed as P. knowlesi infection. With anti-malarial treatment and several medical interventions, patient survived and recovered. One-month medical follow-up was performed after recovery and no recrudescence was noted. This case report highlights the extreme hyperparasitaemic setting, the atypical morphology of P. knowlesi in the patient’s erythrocytes, as well as the medical interventions involved in this successfully treated case.
KeywordsPlasmodium knowlesi Mainland Southeast Asian strain Malaria Hyperparasitaemia Amoeboid morphology Treatment
Malaria is caused by four species of human malaria parasites, namely Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and Plasmodium ovale. Recently, P. knowlesi, a species naturally found in long-tailed macaque (Macaca fascicularis) and pig-tailed macaque (Macaca nemestrina) [1, 2], has been proven to be capable of causing infection in humans [3, 4]. P. knowlesi infection is prevalent in Southeast Asia. Imported cases have been reported in European countries due to eco-tourism programmes to the forested areas of this region [5–7].
Owing to its 24-hour erythrocytic stage development [8, 9], P. knowlesi has raised concern in the medical community regarding its high potential to replicate quickly, which may result in massive erythrocyte destruction in patients. Knowlesi malaria shows a fatality rate that is comparable, if not higher than that of falciparum malaria [10, 11]. The severity of knowlesi malaria is significantly associated with high parasitaemia . Nevertheless, knowlesi malaria cases with hyperparasitemic setting were not frequently found except in Malaysian Borneo [5, 6, 10–16]. Recently, a case of P. knowlesi reinfection in peninsular Malaysia was reported, with a parasitaemia of 2.0% during the first infection and 2.5% during the second infection . Plasmodium knowlesi infection with extreme hyperparasitaemia, higher than that has never been reported in peninsular Malaysia. Microscopic identification of P. knowlesi is difficult for many laboratory technicians due to the overlapping morphology with that of other human malaria parasites, such as P. falciparum and P. malariae[3, 10, 12, 13, 18]. Here, the first hyperparasitaemia with atypical amoeboid morphology in a knowlesi malaria case from peninsular Malaysia is reported. Diagnosis was confirmed using microscopic examination of blood smear, polymerase chain reaction (PCR) and sequencing. The treatment strategy applied for this case, and the sequence of diagnostic steps in identifying P. knowlesi infection are described.
A 56-year-old Chinese man was admitted to Hospital Enche’ Besar Hajjah Khalsom, Kluang, Johor with a history of five days of high grade fever, including two days of yellowish discoloration of the skin and extreme tiredness. He worked as a sawmill supervisor at Kluang, Johor. He had no travel history to other countries or deep jungles in Malaysia. However, he often visited a recreational park at the foothill of Gunung Lambak, Kluang, Johor.
Upon admission, he was alert, conscious but appeared lethargic. There was neither neck stiffness nor papilloedema on fundus examination. He was febrile with temperature of 38°C. He had mild pallor, deep jaundice but no petechiae. He was haemodynamically stable, with well perfused peripherals, no signs of tachypnea but the Pulse oximetry (SpO2) monitoring was 72–85% despite good oxygenation on arterial blood gases analysis for about 24 hours after admission. Physical examination of cardiovascular and respiratory systems were normal. He had hepatomegaly, but no splenomegaly.
The initial haematological investigations revealed mild anaemia (Hb level 10.0 g/dL), thrombocytopaenia (48,000 platelets/μl) with normal total white count and haematocrit. Dengue tests for NS1 Ag, IgM and IgG were negative. Serology tests for Hepatitis B surface antigen (HepBsAg), Anti-HCV and HIV tests were negative. Renal function was abnormal as evidenced by high urea and creatinine levels. Liver enzymes were elevated with hyperbilirubinemia of mixed picture. Lactate dehydrogenase (LDH) level was elevated but reticulocyte count was normal and Coombs test was negative. The initial chest radiography revealed normal lung field and no pulmonary congestion.
PCR was conducted to confirm the species of malaria parasite. DNA was extracted and purified from 100 μl of patient’s whole blood using the DNeasy Blood & Tissue Kit (QIAGEN, Valencia, CA). The nested PCR was performed with primers developed previously from 18S ribosomal RNA (18S rRNA) gene . The nest 1 reaction mixture of 25 μl contained 4 μl of DNA template, 5 pmol of genus-specific primers (rPLU1: 5’-TCA AAG ATT AAG CCA TGC AAG TGA-3’and rPLU5: 5’-CCT GTT GTT GCC TTA AAC TCC-3’), 1X PCR Buffer (35 mM Tris-HCl, pH 9.0, 3.5 mM MgCl2, 25 mM KCl, 0.01% gelatin), 0.25 M dNTP and 1 u Taq polymerase and 15.3 μl of nuclease free water. The PCR conditions were as follows: (1) Initial denaturation at 94°C for 4 minutes, (2) 35 cycles of denaturation at 94°C for 30 seconds, annealing at 55°C for 1 minute and extension at 72°C for 1 minute, (3) final extension at 72°C for 10 minutes and a hold temperature of 4°C. The nest 2 amplification mixture contained 4 μl of the nest 1 product and same amounts of buffer, dNTP, Taq polymerase and nuclease free water as in nest 1. The primer sets used in nest 2 PCR were as follow: FAL1: 5’-TTA AAC TGG TTT GGG AAA ACC AAA TAT ATT-3’ and FAL2: 5’-ACA CAA TGA ACT CAA TCA TGA CTA CCC GTC-3’ for P. falciparum; VIV1: 5’-CGC TTC TAG CTT AAT CCA CAT AAC TGA TAC-3’ and V1V2: 5’-ACT TCC AAG CCG AAG CAA AGA AAG TCC TTA-3’ for P. vivax; MAL1: 5’-ATA ACA TAG TTG TAC GTT AAG AAT AAC CGC-3’ and MAL2: 5’-AAA ATT CCC ATG CAT AAA AAA TTA TAC AAA- 3’ for P. malariae; OVAL1: 5’-ATC TCT TTT GCT ATC TTT TTT TAG TAT TGG AGA- 3’ and OVAL2: 5’-GGA AAA GGA CAC ATT AAT TGT ATC CTA GTG-3’ for P. ovale; Pmk8: 5’-GTT AGC GAG AGC CAC AAA AAA GCG AAT-3’ and Pmkr9: 5’-ACT CAA AGT AAC AAA ATC TTC CGT A-3’ for P. knowlesi. The nest 2 amplification conditions were similar to that of nest 1 except that the annealing temperature of 58°C was used for the species-specific primers. The PCR products were purified with QIAquick Gel Extraction Kit (QIAGEN, Valencia, CA) and cloned into pGEM®-T Vector Systems (Promega, Wisconsin, USA), before sending to DNA sequencing service provider. Ethical approval for this study was obtained from the Medical Ethics Committee of University Malaya Medical Centre (Ref No. 817.18).
One-month-clinical follow up investigations performed on the patient of this case
TWBC (× 10 3 /μl)
Platelet (× 10 3 /μl)
PaCO 2 (mmHg)
PaO 2 (mmHg)
HCO 3 (mmol/L)
For malaria diagnosis, light microscopic examination of thin blood smear is still the gold standard. The morphology of P. knowlesi overlaps with that of P. falciparum and P. malariae at different erythrocytic stages [1, 2, 13, 18, 21]. Therefore, microscopic identification of P. knowlesi is extremely difficult even with experienced laboratory personnel. Nevertheless, this method still contributes significantly to the species identification in malaria infection. With complete patient’s travel history, rapid diagnostic test, peripheral blood platelet characterization and parasiteamia counting, microscopic examination still serves as part of the first-line method to verify the aetiological agent of the infection. For this case report, the identification keys for P. knowlesi were obtained from previous studies conducted on monkeys and humans [1, 2, 9, 13, 21]. Unlike the observation in other studies, the blood smear in this case shows abundant parasites in highly amoeboid form (Figure 1C). Presence of malaria parasites with highly amoeboid morphology should not be straight forwardly determined as P. vivax, which is often accompanied with less fatal outcomes.
For this case report, the anti-malarial regime of IV artesunate and doxycycline worked efficiently in killing most of the parasites within one day after the course of treatment. Therefore, this formulation can serve as an alternative regime for treating knowlesi malaria besides the treatment formulation mentioned in previous studies [9, 12, 14], especially for patients with Glucose-6-phosphate Dehydrogenase (G6PD) deficiency, who cannot use quinine. Due to its fast quotidian erythrocytic cycle, P. knowlesi infection carries high risk of acute haemolytic anaemia that is potentially fatal. Therefore, patients infected with P. knowlesi should be treated immediately and have their haematological profile monitored closely from time to time. Meanwhile, blood transfusion may be a crucial supplementary strategy in treating patients with hyperparasitemia. Blood transfusion assists by compensating the destruction of erythrocytes upon rupture of schizonts. This is especially important for patients with compromised bone marrow erythropoietic activity. Indeed, such medical intervention was mentioned previously in treatment of complicated knowlesi malaria . The causes of acute kidney injury in this patient may be due to the combination of factors, which include hypovolemia secondary to dehydration, hyperparasitemia, and haemoglobinaemia arising from haemolysed infected erythrocytes. During this period of time, hemodialysis was vital for patient’s survival as his renal function was impaired. Since renal involvement is not rare in pathogenesis of P. knowlesi infection [10–12], it is important to note that patient care and treatment for malaria cases should not be focused solely on clearing the parasites, and should not stop right after the parasites are cleared completely from the blood stream. This is especially crucial for cases with hyperparasitemia.
As mentioned by previous studies, anaemia, thrombocytopaenia and abnormal renal function were noted in our patient [9–12]. Besides, the deep jaundice noticed on this patient upon admission is the result of large-scale haemolysis that leads to overproduction of bilirubin. Another finding from this case that is worth mentioning is the patient’s “anaemia accompanied with normal reticulocyte reading” upon admission. In general, the erythropoietic activity in the bone marrow will be up-regulated when large amount of erythrocytes are cleared from the blood stream as a compensatory mechanism. Consequently, the peripheral reticulocyte reading will increase. Therefore, reticulocyte count serves as an indicator of erythropoietic activity [22, 23]. Normal reticulocyte reading in an anaemic setting suggests suppression of erythropoiesis. Unlike P. falciparum[24, 25], the suppression of erythropoietic activity in human P. knowlesi infection has not been investigated thoroughly as to date. Therefore, the impact of P. knowlesi infection on the integrity of erythropoiesis deserves more attention in knowlesi malaria research.
Previously, cases reported from peninsular Malaysia and other places of mainland Southeast Asian region were mostly accompanied with low parasitaemia [5, 15, unpublished data]. This case report shows that P. knowlesi isolates from the mainland Southeast Asian regions are capable of causing hyperparasitemic infections. Nevertheless, with prompt and appropriate therapeutic intervention, the patient has a higher chance of recovery. With systematic and detailed study on thin smear using light microscope, supplemented with physical examination, preliminary identification of P. knowlesi is still possible, albeit with some difficulty.
A successfully treated hyperparasitemic knowlesi malaria case with atypical amoeboid morphology from peninsular Malaysia is described. In view of the challenges in diagnosis, healthcare workers should be aware of such atypical amoeboid morphology in knowlesi malaria samples. Besides, combination of artesunate and doxycyline can be an alternative treatment regime for knowlesi malaria cases. The renal function of knowlesi malaria patients should be monitored closely throughout the course of treatment, even after the parasites are successfully cleared from the blood stream.
Consent was granted by patient for the publication of this case report.
The study was supported by University of Malaya, High Impact Research Fund (E000051-20001) and UMRG (PV044/2012A). We would like to acknowledge the nursing staff and doctors from Medical wards, Intensive Care Unit, Emergency Department, Laboratory Department and the Hospital Director of Hospital Enche’ Besar Hajjah Khalsom, as well as the staff of Department of Parasitology, University of Malaya.
- Sinton JA, Mulligan HW: A critical review of the literature relating to the identification of the malarial parasites recorded from monkeys of the family Ceropithecidae and Colobidae. Records of the Malaria Survey of India. 1932, 3: 357-380.
- Sinton JA, Mulligan HW: A critical review of the literature relating to the identification of the malarial parasites recorded from monkeys of the family Ceropithecidae and Colobidae. Records of the Malaria Survey of India. 1933, 3: 381-443.
- Singh B, Lee KS, Matusop A, Radhakrishnan A, Shamsul SS, Cox-Singh J, Thomas A, Conway DJ: A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet. 2004, 363: 1017-1024. 10.1016/S0140-6736(04)15836-4.View ArticlePubMed
- White NJ: Plasmodium knowlesi: the fifth human malaria parasite. Clin Infect Dis. 2008, 46: 172-173. 10.1086/524889.View ArticlePubMed
- Kantele A, Marti H, Felgar I, Müller D, Jokiranta TS: Monkey malaria in a European traveler returning from Malaysia. Emerg Infect Dis. 2008, 14: 1434-1436. 10.3201/eid1409.080170.PubMed CentralView ArticlePubMed
- Bronner U, Divis PCS, Färnert A, Singh B: Swedish traveler with Plasmodium knowlesi malaria after visiting Malaysia Borneo. Malar J. 2009, 8: 15-19. 10.1186/1475-2875-8-15.PubMed CentralView ArticlePubMed
- Tang TT, Salas S, Ali-Tammam M, Martinez MC, Lanza M, Arroyo E, Rubio JM: First case of detection of Plasmodium knowlesi in Spain by Real Time PCR in a traveller from Southeast Asia. Malar J. 2010, 9: 219-224. 10.1186/1475-2875-9-219.PubMed CentralView Article
- Knowles R, Das Gupta BM: A study of monkey-malaria, and its experimental transmission to man. Indian Medical Gazette. 1932, 67: 301-320.
- Coatney GR, Collins WE, Warren M, Contacos PG: The Primate malarias. 1971, Bethesda, Md: U.S. Department of Health, U. S. Government Printing Office
- Daneshwar C, Davis TME, Cox-Singh J, Rafáee MZ, Zakaria SK, Divis PCS, Singh B: Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis. 2009, 49: 852-860. 10.1086/605439.View Article
- William T, Menon J, Rajahram G, Chan L, Ma G, Donaldson S, Khoo S, Fredrick C, Jelip J, Anstey NM, Yeo TW: Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia. Emerg Infect Dis. 2011, 17: 1248-1255. 10.3201/eid1707.101017.PubMed CentralView ArticlePubMed
- Cox-Singh J, Davis TME, Lee KS, Shamsul SSG, Matusop A, Ratnam S, Conway DJ, Singh B: Plasmodium knowlesi malaria in humans is widely distributed and potentially life-threatening. Clin Infect Dis. 2008, 46: 165-171. 10.1086/524888.PubMed CentralView ArticlePubMed
- Lee KS, Cox-Singh J, Singh B: Morphological features and differential counts of Plasmodium knowlesi in naturally acquired human infections. Malar J. 2009, 8: 73-82. 10.1186/1475-2875-8-73.PubMed CentralView ArticlePubMed
- Kantale A, Jokiranta TS: Review of cases with the emerging fifth human malaria parasite, Plasmodium knowlesi. Clin Infect Dis. 2011, 52: 1356-1362. 10.1093/cid/cir180.View Article
- Jongwutiwes S, Putaporntip C, Iwasaki T, Sata T, Kanbara H: Naturally acquired Plasmodium knowlesi malaria in human, Thailand. Emerg Infect Dis. 2004, 10: 2211-2213. 10.3201/eid1012.040293.PubMed CentralView ArticlePubMed
- Willmann M, Ahmed A, Siner A, Wong IT, Woon LC, Singh B, Krishna S, Cox-Singh J: Laboratory markers of disease severity in Plasmodium knowlesi infection: a case control study. Malar J. 2012, 11: 363-10.1186/1475-2875-11-363.PubMed CentralView ArticlePubMed
- Lau YL, Tan LH, Chin LC, Fong MY, Noraishah MA, Rohela M: Plasmodium knowlesi reinfection in human. Emerg Infect Dis. 2011, 17: 1314-1315. 10.3201/eid1707.101295.PubMed CentralView ArticlePubMed
- Baird JK: Malaria Zoonoses. Travel Med Infect Dis. 2009, 7: 269-277. 10.1016/j.tmaid.2009.06.004.View ArticlePubMed
- BLAST: [http://blast.ncbi.nlm.nih.gov]
- Tamura K, Dudley J, Nei M, Kumar S: MEGA 4: Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007, 24: 1596-1599. 10.1093/molbev/msm092.View ArticlePubMed
- Fong YL, Cadigan FC, Coatney GR: A presumptive case of naturally occuring Plasmodium knowlesi malaria in man in Malaysia. Trans R Soc Trop Med Hyg. 1971, 65: 839-840. 10.1016/0035-9203(71)90103-9.View ArticlePubMed
- Rowan RM: Reference method, quality control and automation of reticulocyte count. Pure Appl Chem. 1991, 63: 1141-1145. 10.1351/pac199163081141.View Article
- Riley RS, Ben-Ezra JM, Ann Tidwell MT: Reticulocyte enumeration: past and present. Laboratory Medicine. 2001, 32: 599-608. 10.1309/U0PB-1XCK-FLQ7-V36V.View Article
- Awandare GA, Kempaiah P, Ochiel DO, Piazza P, Keller CC, Perkins PJ: Mechanisms of erythropoiesis inhibition by malarial pigment and malaria induced pro-inflammatory mediators in an in vitro model. Am J Hematol. 2011, 86: 155-162. 10.1002/ajh.21933.View ArticlePubMed
- Perkins DJ, Were T, Davenport GC, Kempaiah P, Hittner JB, Ong’echa JM: Severe malarial anemia: innate immunity and pathogenesis. Int J Biol Sci. 2011, 7: 1427-1442.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.